Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMEJOPL)

• Drug Name: 2,2-bipyridyl derivative 5 Drug Info
• Synonyms: PMID25468267-Compound-21
• Cross-matching ID: TTD Drug ID: DMEJOPL

Molecule-Related Drug Atlas

Drug(s) Targeting Lysine-specific demethylase 4 (KDM4)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
N-oxalylglycine derivative 2	DMDJC96	N. A.	N. A.	Patented	[1]
Pyridine-2,4-dicarboxylic acid derivative 1	DMZSTCQ	N. A.	N. A.	Patented	[1]
Hydroxamate analog 3	DMDQYJ1	N. A.	N. A.	Patented	[1]
PMID25468267-Compound-51	DMNPC0H	N. A.	N. A.	Patented	[1]
PMID25468267-Compound-54	DMI93AX	N. A.	N. A.	Patented	[1]
N-oxalylglycine derivative 3	DMQF0RY	N. A.	N. A.	Patented	[1]
PMID25468267-Compound-48	DMBPT9Z	N. A.	N. A.	Patented	[1]
Pyridine-2,4-dicarboxylic acid derivative 2	DMGCMF5	N. A.	N. A.	Patented	[1]
Pyridine-2,4-dicarboxylic acid derivative 3	DMCUP4L	N. A.	N. A.	Patented	[1]
PMID25468267-Compound-53	DMONWYI	N. A.	N. A.	Patented	[1]

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Lysine-specific demethylase 4 (KDM4)	TT0RGE9	NOUNIPROTAC	Inhibitor	[1]

References

• [1] KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):135-44.